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Abstract 
Topically applied tetracaine is a local anaesthetic. A novel HPLC method for rapid and 
sensitive analysis of tetracaine was developed and compared with a short end direction 
capillary zone electrophoresis (CZE) method (Al-Otaibi, Tucker, Johnston and Perrett 2009). 
The method was developed and validated for the separation and quantification of tetracaine in 
skin samples removed by “tape stripping”. Tetracaine was extracted from tape with 100% 
methanol, which was then diluted to 50% with water for injection. Tetracaine and internal 
standard, procaine, were separated, on a reversed phase Luna PFP(2), 3µm, 150 mm × 4.6 
mm column at ambient temperature using isocratic elution with KH2PO4 buffer (pH 2.5) and 
methanol (35:65,v:v). The flow rate was 1 ml/min, with detection at 312 nm. The limit of 
quantification for tetracaine was 0.03μg/ml. Calibration lines were linear with r2 values 
greater than 0.99. Within and between assay imprecision and the percentage of inaccuracy for 
the QC samples including lower and upper limits of quantitation were <6% and <10%. The 
absolute mean recovery of tetracaine was > 92%. Compared to CZE, the mean percentage 
error and the absolute mean percentage error was 0.62 and 6.29. Both methods were 
compared in a number of pharmacokinetic studies. 
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Introduction 
Tetracaine (amethocaine, 2-dimethylaminoethyl 4-butylaminobenzoate, C15H24N2O2.HCl), is 
a potent local anaesthetic of the amino ester group, and is used for topical anaesthesia in 
ophthalmology, spinal anaesthesia and nerve block. It is also the first alternative anaesthetic 
for nasal septoplasty since cocaine (Drivas, Hajiioannou, Lachanas, Bizaki, Kyrmizakis and 
Bizakis 2007). Tetracaine, as the hydrochloride, can be formulated in solutions, creams, gels, 
and as the base in ointments. The topical formulation of tetracaine gel as a local anaesthetic 
was developed in the early 1990s, enabling a more rapid and long duration of action than the 
mixture of lidocaine and prilocaine, known as EMLA cream (Bishai, Taddio, Bar-Oz, 
Freedman and Koren 1999, Boyd and Jacobs 2001, Martindale, Reynolds and Parfitt 1996, 
McCafferty, Woolfson and Boston 1989, Woolfson, McCafferty and Boston 1990). The onset 
of action is 30 to 45 minutes, while EMLA cream is about 1 hour, without any risk of 
methemoglobinaemia.  
HPLC with UV detection has been used for determination of tetracaine in plasma 
(Mazumdar, Tomlinson and Faulder 1991, Menon and Norris 1981, Murtaza, Jackman, 
Alexander, Lleshi-Tali, Winnie and Igic 2001, Qin, Jiao, Zhong, Shi, Zhang, Li and Cui 
2010) and was capable of detecting tetracaine and its major metabolite (Figure 1). All of 
these methods have relied upon ion-pairing agents in conjunction with ODS C18 stationary 
phase to achieve good separation for tetracaine although peak shape could still be 
problematical. In an earlier we reported a simple CZE method for tetracaine (Al-Otaibi, 
Tucker, Johnston and Perrett 2009). 
In this study, a novel rapid and sensitive HPLC-UV method for analysis of topically applied 
tetracaine was developed using a pentafluoryl phenyl PFP(2) HPLC column that allowed fast 
analysis, sharp peak resolution without the need for ion-pairing agents. Thus, using simple 
and rapid techniques such as CE or HPLC-UV is possible as expensive techniques such as 
LC-MS are not required. In addition, HPLC techniques can be compared with CE to find out 
more appropriate and reliable methods. In this study, we validated the HPLC-UV method and 
compared it to previously published CZE-UV  
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Materials and methods 
 
General chemicals 
 
Tetracaine hydrochloride (HCl; lot no. 065k1501; 99.9% purity) for calibrator and control 
sample preparation, 4-Butyaminobenzoic acid (Lot no 02514BJ; 97% purity), tetracaine 
major metabolite, and procaine hydrochloride (HCl; lot no. 114k0569; 100% purity), the 
internal standard were obtained from Sigma Aldrich (Poole, UK). HPLC-grade solvents were 
obtained from Rathburn Chemicals Ltd (Walkerburn, UK). All other AR grade reagents were 
obtained from Merck (BDH) Ltd (Poole, UK). 
 
Adhesive tape 
 
Samples were obtained by a tape stripping technique from the skin of healthy volunteers, who 
had received topical tetracaine. The adhesive tape used in this study was 19 mm width, Tesa 
4205 PV5, Beiersdorf, Hamburg Germany, supplied by TESA UK. The concentration of the 
drug in such samples can be higher than that in plasma samples of topically applied drugs 
(Bareggi, Pirola and De Benedittis 1998). 
 
Chromatographic conditions and instrumentation 
 
A Shimadzu LC-6A pump, Gilson 231 autosampler fitted with a 200 μL injector loop, Gilson 
diluter 401 coupled to a Shimadzu SPD-6A UV/Vis detector was used. Separations were 
carried out using a Luna PFP (2) column, 3µm, 150mm x 4.60 mm from Phenomenex 
Macclesfield U.K. The injection volume was 10 µL. The analytes were eluted using isocratic 
elution at 1 mL/min with KH2PO4 buffer (pH 2.5) and methanol (35:65, v:v) and were 
monitored by ultraviolet absorption at 312 nm. The data acquisition system consisted of a 
data interface (HP 35900 interface) and HP Chemstation, version A.04.01. The software was 
operated under Windows 95 environment. 
 
Sensitivity 
 
The lower limit of detection was determined as the concentration of tetracaine that had a peak 
height three times higher than the baseline noise. The lower limit of quantification was 
defined as the lowest tetracaine concentration that can be quantified with a CV<10%. 
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Recovery 
 
Recovery of tetracaine was calculated by dividing the peak area of the standard samples 
spiked with tetracaine by the peak area of the same tetracaine concentration in 50% MeOH. 
 
Stability 
 
The stability of tetracaine was determined using tape samples spiked with tetracaine at 100 
µg/ml stock solutions. Aliquots from this solution were injected into the HPLC after each 
freeze / thaw cycles stored at –20 ºC. 
 
Calibrators and quality control samples 
 
Calibrator 
50 ml of tetracaine stock standard solution was diluted to 100 ml with 50% v/v aqueous 
MeOH to produce a stock solution (2.5 mg/ml). Working calibration solutions were prepared 
by diluting the stock solution with 50% v/v aqueous MeOH, as follow 0.03, 0.1, 0.3, 1, 3, 10, 
30, 100 µg/ml. 0.03 and 100 µg/ml were used as lower limit of quantitation (LLOQ) and 
upper limit of quantitation (ULOQ), respectively. 
Quality control (QC) samples 
A sub-stock (QC 4, 1.25 mg/ml) was prepared. Working controls were prepared by diluting 
the sub stock with 50% v/v aqueous MeOH, as follow 0.5, 5, 50 µg/ml. 
Calculating inaccuracy and imprecision 
 
Inaccuracy was tested by the determination of low, medium and high quality control samples, 
together with the LLOQ and ULOQ samples. Each sample contained tetracaine. The nominal 
values for the low, medium and high control samples were 0.5, 5, 50 µg/ml, respectively. The 
nominal values for the ULOQ and LLOQ were the same nominal concentration as the highest 
and the lowest calibration standards, respectively. 
Assay imprecision was measured both within and between batch by the analysis of three 
control samples, the LLOQ and the ULOQ. Within-batch and between-batch imprecision, 
regression coefficient and the slope of the calibration line were calculated from the peak area 
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ratio by excel 2007, using internationally agreed methods (ISO-5725 1994). The statistical 
analysis and graphical presentation used Excel 2007. 
 
Extraction of tetracaine from tape samples  was has previously described (Al-Otaibi, Tucker, 
Johnston and Perrett 2009). 
 
Results  
 
HPLC Separation 
 
We tested four different HPLC columns (C8, C18, phenyl and PFP). The PFP column 
achieved the best separation and peak resolution for tetracaine and the internal standard 
procaine. Mobile phase pHs ranging from 2-8 were also studied and the optimum pH for 
retention was found to be 2.5. (Figure 2) 
Sensitivity 
 
The limit of detection (LLOD) for tetracaine was 3 ng/ml. The limit of quantification 
(LLOQ) was 30 ng/ml. 
 
Specificity 
 
Error! Reference source not found.A shows a chromatograph of a time zero patient sample 
with no significant interfering peaks at the retention time of procaine (150 µg/ml) or 
tetracaine, compared with figure 2B, 10 μg/ml tetracaine, and figure 2C, 1 hour post-
treatment chromatograph, at λmax of 312 nm.  
Linearity 
 
Figure 3 shows the calibration line containing the eight non-zero calibrators assayed. 
Nominal values were 0.03, 0.1 0.3, 1, 3, 10, 30, 100 μg/ml tetracaine and 150 μg/ml procaine. 
Six batches of calibration curve were plotted using the area ratio of tetracaine to IS Vs known 
concentration of tetracaine. All the results were calculated using a 1/x
2
 weighted quadratic 
regression. 
 
Accuracy and precision 
 
Accuracy was tested by determination of low, medium and high quality control samples, 
together with the LLOQ and ULOQ samples. Each control sample contained tetracaine. The 
Page 7 of 18 
 
nominal values for the low, medium and high control samples were 0.5, 5, 50 µg/ml 
respectively. The nominal values for the ULOQ and LLOQ were the same nominal 
concentration as the highest and the lowest calibration standards, respectively. 
Assay precision was measured both within and between batch by the analysis of three control 
samples, the LLOQ and the ULOQ. 
 
Within assay reproducibility  
For within and between batch precision the LLOQ and ULOQ, the three control samples 
were each assayed six times during one assay. The CV for imprecision and the percentage 
inaccuracy for all the quality control samples including LLOQ and ULOQ was below 10 and 
5%, respectively. 
Between assay repeatability 
 
The mean concentration from each assay was used to calculate the between assay 
reproducibility. The CV for imprecision and percentage inaccuracy for all the quality control 
samples including LLOQ and ULOQ was below 7 and 5%, respectively. 
Within and between batch precision was calculated using FDA agreed methods (FDA 2001). 
 
Stability 
 
The CV% of 100 μg/ml tetracaine was less than 2%, when injected into the HPLC after each 
freeze / thaw cycle. 
 
Recovery 
 
The absolute recovery of tetracaine ranged from 79 to 104%. The result was obtained by 
dividing the peak height for specific tetracaine concentrations in methanol: water, 50:50 
solutions and the peak height of the same concentration in skin tape stripping soaked in 
methanol:water, 50:50 from time zero (sample 0). 
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Method comparison 
 
Tape samples obtained from patients’ skin were successfully analyzed by both the new HPLC 
method and the CZE technique (Al-Otaibi, Tucker, Johnston and Perrett 2009). The limit of 
quantification for the HPLC method for tetracaine was 0.03 μg which was better than 
reported for the CZE method. The calibration lines for CE and HPLC were linear for 25 – 
1200 μg/ml and 0.03 – 100 μg/ml, respectively and both had r2 values greater than 0.99. The 
CV% for both within and between assay imprecision and the percentage of inaccuracy for the 
quality control samples including lower and upper limits of quantitation for HPLC were <6% 
and <10%, respectively, and for CE were < 12.1% and < 11%, respectively. The shorter 
migration times obtained for tetracaine (1.36 min) are an advantage of CE compared to 3.75 
min retention in HPLC. An internal standard was used to minimize injection volume 
variability, and error resulting from methanol evaporation in sample. The absolute mean 
recovery of tetracaine in HPLC was > 92%, and in CE was > 97%.  
The two methods of measurement were compared to find out if there was any difference 
related to the analysis. The analyzed data were calculated and plotted for both methods, 
Figure 4 shows Bland–Altman analysis was in a range of ± 1.96 SD from the mean, and 
Table 4 shows the mean, standard deviation, and standard error of the mean percentage error 
(MPE) and the absolute mean percentage error (AMPE) between the HPLC and the CE 
measurements. 
Discussion 
 
In this study an HPLC method was developed, optimized and validated for analysis of 
topically applied tetracaine. This is the first HPLC method to be developed for this purpose. 
The new HPLC method resulted in a good separation with excellent resolution and minimum 
peak tailing. There was no need for ion-pairing or gradient elution. The chromatography was 
fast, clean and ideally suited for PK studies when lots of samples are to be assayed. However 
it is difficult to rationalise the precise separation mechanism on a PFP column. PFP is known 
to exhibit both normal and reversed phase characteristics (Marin and Barbas 2006). The 
HPLC on a PFP column used in this study gave an unexpected separation with a short 
retention time of 2.6 and 3.8 min for procaine and tetracaine, respectively. All the validation 
results met the international requirements as outlined by the FDA’s 2001 bioanalytical 
method validation guidelines (FDA 2001).  
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HPLC and CE methods with UV detection have been compared for the determination of tape 
samples obtained from healthy volunteers given tetracaine as part of a pharmacokinetic study. 
UV detection was chosen to be used for its simplicity and low cost. Although the HPLC 
method was better in terms of sensitivity, both methods in this study measured all samples 
obtained without any problems, including the lower concentrations obtained in the tape 
samples. The data obtained were within ±1.96 SD, and 17% error of the difference. 
Nevertheless the purpose of this study was to develop a fast and simple analytical method, to 
determine tetracaine in skin using tape samples from 12 healthy volunteers given tetracaine 
as part of a pharmacokinetic drug delivery study. Although the imprecision was higher, the 
lower operation costs and volume of electrolyte used, and faster running time made CE 
preferable to HPLC for this kind of study. This observation is in agreement to that of other 
authors in comparisons between the two methods (Aurora Prado, Steppe, Tavares, Kedor-
Hackmann and Santoro 2005, Carlucci, Anzini, Rovini, Cattaneo, Merlini and Tabucchi 
2007, Clohs and McErlane 2003, Kocevar, Glavac, Injac and Kreft 2008, Kowalski and 
Plenis 2007, Muscarella, Iammarino, Centonze and Palermo 2005). Sometimes HPLC was 
not useful (Hilz, de Jong, Kabel, Schols and Voragen 2006), due to the physicochemical 
properties of the analyte resulting in poor resolution and reproducibility (Bexheti, Anderson, 
Hutt and Hanna-Brown 2006). 
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Table 1 The within batch imprecision and inaccuracy of three quality controls together 
with LLOQ and ULOQ. 
Data LLOQ QC1 QC2 QC3 ULOQ 
Nominal Conc (μg/ml) 0.03  0.50 5.0 50.0 100.0 
Mean 0.03 0.51 4.86 47.19 95.97 
SD 0.001 0.002 0.019 0.105 2.614 
CV% 4.02 0.41 0.40 0.22 2.73 
Inaccuracy % 3.40 2.65 2.83 5.63 4.25 
 
 
 
 
 
 
Table2 The between batch imprecision and inaccuracy of three quality controls together 
with LLOQ and ULOQ. 
Data LLOQ QC1 QC2 QC3 ULOQ 
Nominal Conc (μg/ml) 0.03  0.50 5.0 50.0 100.0 
n = 6 6 6 6 6 
Mean 0.03 0.51 5.03 48.46 92.29 
SD 0.001 0.004 0.083 0.492 0.986 
CV% 3.66 0.85 1.65 1.02 1.07 
Inaccuracy % 4.38 1.61 1.41 3.46 7.71 
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Table 3 Three freeze/ thaw cycles of the 100 µg/mL stock solutions. 
Data Standard 100 µg/ml 
Time 0 100.78 
Freeze / thaw week 1 101.2 
Freeze / thaw week 2 99.79 
Freeze / thaw week 3 103.23 
CV% 1.42 
 
 
 
 
 
 
Table 4 The mean percentage error and the absolute mean percentage error between the 
HPLC and the CE measurements. 
Data MPE AMPE 
Mean 2.23 7.86 
SD 8.08 4.63 
n 102 102 
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Figure 1 Chemical structures of tetracaine, procaine, and 4-butylaminobenzoic acid. 
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Figure2 A) Chromatograph obtained from extracted tape of time zero patient 
sample spiked with IS of 150 μg/ml procaine, displayed at 312 nm. 
B) Chromatograph of extracted tape of 10 μg/ml tetracaine spiked with IS 
of 150 μg/ml procaine, run under the optimum conditions and displayed at 312 
nm. 
C) Chromatograph of extracted tape of 1 hour post-treatment spiked with 
IS of 150 μg/ml procaine, displayed at 312 nm. 
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Figure 3 Typical calibration curve and linearity of tetracaine (HPLC). 
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Figure 4 Bland–Altman analysis: correlation of HPLC and CE in the analysis of 
tetracaine tape stripping samples, (SD = ±8.018, Mean = 2.231, n=102). 
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